• Wasting syndrome
• Severe pain
• Severe nausea
• Severe or persistent muscle spasms
• Post-traumatic stress disorder
• Chronic pain
Senate Bill 923, passed on April 14, 2014, authorized access to medical cannabis by patients with serious illnesses. To manage the medical marijuana industry in Maryland, the state’s Congress appointed the Natalie M. LaPrade Medical Cannabis Commission (MMCC), a 15-member committee.
Application deadlines for stage one of the licensing process have passed, and the Natalie M. LaPrade Maryland Medical Cannabis Commission (the Commission) will no longer be accepting submissions from individuals intending to grow, process, or dispense medical marijuana in the state of Maryland. The first dispensaries have already opened in Maryland; these businesses were licensed two-years ago during the licensing process in 2016.
A total of 1081 applications were submitted to the Commission, of which there were:
The Illinois Medical Cannabis Pilot Program follows rules passed by the Department of Public Health, Department of Revenue, Department of Financial & Professional Regulation, and the Department of Agriculture.